← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tendel Therapies Inc.
Kensington, CA
$4,972,658
Total funding
7
Grants
Funding over time
peak $2.2M · FY2020–25$2.5M$1.9M$1.3M$625K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,972,658 · 7
By mechanism
R44$2,571,682 · 2
R41$1,199,983 · 3
R43$601,013 · 1
N43$599,980 · 1
Investigators at Tendel Therapies Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine$1,000,000
R44 · FY2023 · AI
Optimizing SIV reservoir depletion by Tendel bsAb-98$999,991
R44 · FY2025 · AI
TFH-TARGETING GENETIC ADJUVANTS TO PROMOTE DURABLE ANTI-INFLUENZA STEM ANTIBODIES IN OLDER ADULTS.$599,980
N43 · FY2023 · AI
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine$571,691
R44 · FY2024 · AI
Genetic adjuvants to elicit neutralizing antibodies against HIV$300,930
R43 · FY2023 · MH
Genetic adjuvants to elicit neutralizing antibodies against HIV$300,083
R43 · FY2024 · MH
Nucleic acid-based formulation of cytomegalovirus-vectored HIV vaccines$300,000
R41 · FY2020 · AI
CCR5 immunotoxins as components of HIV cure regimens$300,000
R41 · FY2023 · AI
CCR5 immunotoxins as components of HIV cure regimens$300,000
R41 · FY2022 · AI
Memory-promoting Ad vaccine for long-lived protection against SARS-CoV-2$299,983
R41 · FY2021 · AI